Medifast Reports $17.5 Million Q3 Loss
The wellness firm’s quarterly results signal margin pressures for operators managing similar consumer health models.
Updated on Oct. 26, 2026 in Economic Indicators
Live Poll
Do you trust the long-term outlook for traditional weight-loss companies?
Medifast reported a $17.5 million net loss for the third quarter of 2026 on revenue of $72 million. These results mark a difficult financial period for the health and wellness company as it looks toward the end of the fiscal year.
Why it matters
The company’s quarterly loss underscores ongoing volatility for businesses navigating shifting consumer demand in the health services sector. Operators should watch how such companies adjust their revenue targets and cost structures when facing persistent bottom-line pressures.
Medifast reported a $17.5 million net loss and revenue of $72 million for the third quarter. The firm expects full-year revenue to land between $280 million and $300 million, while projecting a full-year loss between 70 cents and 45 cents per share.
The players
Medifast
A Baltimore-based health and wellness company that offers weight loss and personal health programs.
The details
The Baltimore-based wellness company recorded a loss of $1.57 per share for the quarter ending in September. On an adjusted basis, the loss per share reached 19 cents. Management has provided forward guidance for the fourth quarter, projecting revenue to range between $55 million and $75 million as the firm closes out its 2026 fiscal year.
Timeline
Q3 2026 marked the period of the $17.5 million net loss.
December 2026 marks the end of the current fiscal quarter.
Market Landscape
The report follows a broader pattern observed in the 2026 corporate earnings cycle where wellness providers face compressed margins. This results release offers a benchmark for investors monitoring how mid-market health firms manage shifting consumer spending against established operational costs.
Operators should monitor these revenue projections as a signal of potential softening in the consumer wellness market. Review your own firm's cash flow buffers if you operate in segments that share a similar customer base or cost structure.
The takeaway
Medifast’s third-quarter results highlight the importance of realistic full-year forecasting during periods of financial contraction. Owners should track adjusted earnings-per-share metrics alongside standard revenue figures to gain a clearer picture of underlying operational health.
What happens next
Medifast will close its current fiscal quarter in December 2026.
Further reading
For broader trends on corporate fiscal performance, visit the Economic Indicators section.
Live Poll
Do you trust the long-term outlook for traditional weight-loss companies?
